Spots Global Cancer Trial Database for hepatic carcinoma
Every month we try and update this database with for hepatic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection | NCT03253250 | Chronic Hepatit... Hepatic Carcino... | ETV；TDF；ADV Peginterferon A... | 18 Years - 70 Years | Huashan Hospital | |
| Arterial Base Fluorescence Segmental Positive Staining | NCT04266548 | Hepatic Carcino... | Superselective ... | 20 Years - 85 Years | Chang Gung Memorial Hospital | |
| Combined Locoregional Treatment With Immunotherapy for Unresectable HCC. | NCT04220944 | Hepatic Carcino... | Sintilimab Microwave Ablat... TACE | 18 Years - 80 Years | Shanghai Zhongshan Hospital | |
| Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma | NCT03132740 | Hepatic Carcino... | 18 Years - 70 Years | Zhujiang Hospital | ||
| Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors | NCT03149523 | Colorectal Aden... Hepatic Carcino... Kidney Adenocar... | 18 Years - 80 Years | European Georges Pompidou Hospital | ||
| Endoscopic Ultrasound Guided Liver Biopsy | NCT03307811 | Hepatic Cancer Hepatic Neoplas... Hepatic Carcino... | 22 gauge needle... | 19 Years - | AdventHealth | |
| Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy | NCT01770431 | Hepatic Carcino... | Huaier Granule | 18 Years - 75 Years | Qidong Gaitianli Medicines Co., Ltd | |
| Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma | NCT03572582 | Carcinoma, Hepa... Hepatic Carcino... Hepatocellular ... | Nivolumab TACE | 18 Years - | AIO-Studien-gGmbH | |
| An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 | NCT00884520 | Lung Cancer Squamous Cell C... Head and Neck C... Hepatic Carcino... Renal Cell Carc... | [F-18] VM4-037 | 18 Years - | Siemens Molecular Imaging | |
| A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer | NCT03013712 | Colon Cancer Esophageal Carc... Pancreatic Canc... Prostate Cancer Gastric Cancer Hepatic Carcino... | CAR-T cell immu... | 18 Years - 80 Years | First Affiliated Hospital of Chengdu Medical College | |
| Prehabilitation and Posttransplant Training Program in Liver Transplantation | NCT04246970 | Liver Transplan... Cirrhosis, Live... Hepatic Carcino... | Prehabilitation Prehabilitation... | 18 Years - | Hospital Universitario La Fe | |
| The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection | NCT03253250 | Chronic Hepatit... Hepatic Carcino... | ETV；TDF；ADV Peginterferon A... | 18 Years - 70 Years | Huashan Hospital | |
| Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function | NCT02352935 | Hepatic Carcino... | NanoKnife LEDC ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma | NCT03132740 | Hepatic Carcino... | 18 Years - 70 Years | Zhujiang Hospital | ||
| Prehabilitation and Posttransplant Training Program in Liver Transplantation | NCT04246970 | Liver Transplan... Cirrhosis, Live... Hepatic Carcino... | Prehabilitation Prehabilitation... | 18 Years - | Hospital Universitario La Fe | |
| Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements. | NCT06085976 | Hepatic Carcino... Hepatic Metasta... | Octreotide Placebo | 18 Years - 80 Years | Clinica Universidad de Navarra, Universidad de Navarra | |
| Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies | NCT04258566 | Hepatocellular ... | Optical Molecul... Indocyanine Gre... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Combined Locoregional Treatment With Immunotherapy for Unresectable HCC. | NCT04220944 | Hepatic Carcino... | Sintilimab Microwave Ablat... TACE | 18 Years - 80 Years | Shanghai Zhongshan Hospital | |
| Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma | NCT02834780 | Advanced Hepato... Hepatocellular ... Liver Cancer Liver Neoplasms Hepatic Cancer Hepatic Carcino... | H3B-6527 | 18 Years - | Eisai Inc. | |
| Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension | NCT06245798 | Hepatic Carcino... | transarterial c... | 18 Years - | Tang-Du Hospital | |
| Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | NCT03164382 | Liver Cancer Hepatic Carcino... | FOLFOX regimen Sorafenib 200Mg... | 18 Years - 75 Years | Sun Yat-sen University | |
| Prehabilitation and Posttransplant Training Program in Liver Transplantation | NCT04246970 | Liver Transplan... Cirrhosis, Live... Hepatic Carcino... | Prehabilitation Prehabilitation... | 18 Years - | Hospital Universitario La Fe | |
| A Study to Evaluate Vaccines Against COVID-19 in the Real World | NCT04775056 | Chronic Liver D... Hepatic Carcino... | 18 Years - | Humanity & Health Medical Group Limited | ||
| Development of a Neuronal Microscope | NCT06311396 | Hepatic Carcino... | genetic model | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors | NCT03149523 | Colorectal Aden... Hepatic Carcino... Kidney Adenocar... | 18 Years - 80 Years | European Georges Pompidou Hospital | ||
| A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs | NCT04538313 | Hepatic Carcino... | Tumor infiltrat... | 18 Years - | CAR-T (Shanghai) Cell Biotechnology Co., Ltd. | |
| to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve | NCT05007548 | Hepatic Carcino... | Ga68-Dolacga In... | 20 Years - | National Atomic Research Institute, Taiwan | |
| ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation | NCT05009550 | Hepatic Carcino... | Group ESP Non-blocked Gro... | 18 Years - 65 Years | TC Erciyes University | |
| Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers | NCT04682847 | Liver Neoplasms Hepatic Cirrhos... Hepatic Carcino... Liver Cancer Liver Metastase... Liver Carcinoma Hepatocellular ... Hepatocellular ... Hepatic Atrophy | Ferumoxytol inj... | 18 Years - 89 Years | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | |
| Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden | NCT00960557 | Neoplasm Metast... | Combretastatin ... | 18 Years - | Mateon Therapeutics | |
| Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma | NCT02834780 | Advanced Hepato... Hepatocellular ... Liver Cancer Liver Neoplasms Hepatic Cancer Hepatic Carcino... | H3B-6527 | 18 Years - | Eisai Inc. | |
| Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT Scan | NCT01350726 | Cirrhosis Hepatic Carcino... | 18 Years - 85 Years | Peking Union Medical College Hospital | ||
| ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation | NCT05009550 | Hepatic Carcino... | Group ESP Non-blocked Gro... | 18 Years - 65 Years | TC Erciyes University | |
| A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy | NCT06182865 | Hepatic Carcino... | Ga-68 Dolacga I... | 20 Years - 80 Years | National Atomic Research Institute, Taiwan | |
| Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder | NCT02332551 | Hepatic Carcino... | NanoKnife | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
